| A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine (NCT05239975) | Sinocelltech Ltd. | 2022-04-25 |
| Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass (NCT05101746) | Vanderbilt University Medical Center | 2022-04-25 |
| Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab (NCT05267054) | BeiGene | 2022-04-25 |
| SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer (NCT05319574) | Sun Yat-sen University | 2022-04-24 |
| The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock (NCT05402553) | Noha Mansour | 2022-04-24 |
| Safety and Efficacy of APG-157 in Head and Neck Cancer (NCT05312710) | Aveta Biomics, Inc. | 2022-04-22 |
| Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza (NCT05170009) | Weill Medical College of Cornell University | 2022-04-22 |
| Lefamulin for M. Genitalium Treatment Failures (NCT05111002) | University of Washington | 2022-04-22 |
| Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase (NCT05143840) | University of Alabama at Birmingham | 2022-04-22 |
| DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old (NCT04337450) | PENTA Foundation | 2022-04-22 |
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome (NCT05361668) | Crinetics Pharmaceuticals Inc. | 2022-04-22 |
| Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity (NCT05311215) | Saol Therapeutics Inc | 2022-04-22 |
| A Study of SHR-1802 in Patients With Advanced Solid Tumor (NCT05208177) | Jiangsu HengRui Medicine Co., Ltd. | 2022-04-22 |
| Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids (NCT05348200) | Citius Pharmaceuticals, Inc. | 2022-04-22 |
| PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma (NCT05864105) | Biotheus Inc. | 2022-04-22 |
| Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) (NCT05217667) | Arrowhead Pharmaceuticals | 2022-04-22 |
| Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy) (NCT05095597) | Fundación IVI | 2022-04-22 |
| Redefining FOLFIORINOX in Older Pancreatic Cancer Patients (NCT05360732) | Fox Chase Cancer Center | 2022-04-22 |
| Oral Naltrexone In Pediatric Eating Disorders (NCT05073679) | Rosemary Claire Roden | 2022-04-22 |
| Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy (NCT05251233) | Washington University School of Medicine | 2022-04-21 |
| Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study) (NCT05124483) | University Medical Center Groningen | 2022-04-21 |
| Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation (NCT05371275) | biotx.ai GmbH | 2022-04-21 |
| A Study of CM350 in Patients With Advanced Solid Tumors (NCT05263960) | Keymed Biosciences Co.Ltd | 2022-04-21 |
| Empagliflozin as a Novel Therapy in Refractory Ascites (NCT05430243) | Alexandria University | 2022-04-21 |
| Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer (NCT04791384) | Criterium, Inc. | 2022-04-21 |
| EBA, Safety and Tolerability of Sanfetrinem Cilexetil (NCT05388448) | TASK Applied Science | 2022-04-21 |
| First-in-Human Study of TAK-280 in Participants With Solid Tumors (NCT05220098) | Takeda | 2022-04-21 |
| Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study (NCT05407389) | Kibow Pharma | 2022-04-21 |
| OSU6162 as add-on in SSRI/SNRI-resistant Depression (NCT05641623) | Göteborg University | 2022-04-21 |
| Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma (NCT05248633) | Peking Union Medical College Hospital | 2022-04-21 |
| Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis (NCT05278338) | Shanghai JMT-Bio Inc. | 2022-04-21 |
| Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos (NCT05253573) | University of Oklahoma | 2022-04-20 |
| Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery (NCT05669144) | Tehran University of Medical Sciences | 2022-04-20 |
| Inhaled Isopropyl Alcohol for Treatment of Nausea (NCT05418244) | State University of New York at Buffalo | 2022-04-20 |
| Caudal Epidural Prolotherapy Versus Steroids in Failed Back Surgery Syndrome (NCT05548738) | Alexandria University | 2022-04-20 |
| Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements (NCT05174650) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-04-20 |
| Helicobacter Pylori Eradication Therapy for Epileptic Children (NCT05297695) | Sohag University | 2022-04-20 |
| Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer (NCT05158062) | Kosei Hasegawa, MD, PhD | 2022-04-20 |
| Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma. (NCT05323890) | Shandong Cancer Hospital and Institute | 2022-04-20 |
| Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study (NCT05053152) | NRG Oncology | 2022-04-20 |
| Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma (NCT05508347) | Sichuan Cancer Hospital and Research Institute | 2022-04-20 |
| An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis (NCT05214794) | Maruho Co., Ltd. | 2022-04-20 |
| Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer (NCT04329065) | University of Washington | 2022-04-20 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| The SUPPORT Study: Effectiveness and Usability of a Web-Enabled Resource for Postpartum Mental Health (NCT05382884) | University of British Columbia | 2022-04-20 |
| Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) (NCT05275686) | Cedars-Sinai Medical Center | 2022-04-20 |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) (NCT04965597) | Fred Hutchinson Cancer Center | 2022-04-19 |
| A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia (NCT05332366) | LEO Pharma | 2022-04-19 |
| To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer (NCT05212701) | Dompé Farmaceutici S.p.A | 2022-04-19 |
| A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain (NCT05359133) | Wex Pharmaceuticals Inc. | 2022-04-19 |
| Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia (NCT05281809) | John Lister | 2022-04-19 |
| Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (NCT05445076) | Biocad | 2022-04-19 |
| Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD) (NCT05279157) | Vissum, Instituto Oftalmológico de Alicante | 2022-04-19 |
| A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression) (NCT05135715) | RemeGen Co., Ltd. | 2022-04-19 |
| Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant (NCT05103904) | Emory University | 2022-04-19 |
| Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (NCT05047185) | Pharvaris Netherlands B.V. | 2022-04-19 |
| A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes. (NCT04840199) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-04-19 |
| A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 (NCT05348785) | Biogen | 2022-04-19 |
| A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study) (NCT04945018) | Heartseed Inc. | 2022-04-19 |
| A Study of WJ05129 in Advanced Malignant Solid Tumors (NCT05326035) | Suzhou Junjing BioSciences Co., Ltd. | 2022-04-19 |
| Different Doses of ZED1227 vs. Placebo in NAFLD (NCT05305599) | Dr. Falk Pharma GmbH | 2022-04-19 |
| ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases (NCT05265013) | Rakuten Medical, Inc. | 2022-04-19 |
| Transverse Abdominus Plane Block Study (NCT05216055) | University of Colorado, Denver | 2022-04-19 |
| Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors (NCT05223231) | Nanjing Leads Biolabs Co.,Ltd | 2022-04-19 |
| Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD (NCT04910152) | Hannah Choe, MD | 2022-04-19 |
| Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae (NCT05294588) | University of North Carolina, Chapel Hill | 2022-04-18 |
| Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer (NCT05309629) | Qilu Pharmaceutical Co., Ltd. | 2022-04-18 |
| Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies (NCT05342506) | Peking Union Medical College Hospital | 2022-04-18 |
| The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study (NCT04726241) | PedAL BCU, LLC | 2022-04-18 |
| A Study of Anti-IL-6R mAb Injection in Patients With iMCD (NCT05345522) | Beijing VDJBio Co., LTD. | 2022-04-18 |
| Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome (NCT05279118) | All India Institute of Medical Sciences | 2022-04-18 |
| Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 (NCT05289726) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-04-18 |
| Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers (NCT05625477) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 2022-04-18 |
| Levodopa for Diabetic Retinopathy (NCT07444892) | Emory University | 2022-04-18 |
| Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years. (NCT05330871) | Seventh Medical Center of PLA General Hospital | 2022-04-17 |
| Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma (NCT05282433) | Zhongnan Hospital | 2022-04-16 |
| Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. (NCT05341206) | Chang Gung Memorial Hospital | 2022-04-15 |
| Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron (NCT05342818) | Tanta University | 2022-04-15 |
| Efficacy of Tazarotene in Treatment of Verruca Plana (NCT05314127) | Zagazig University | 2022-04-15 |
| Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer (NCT05322499) | Zhejiang Cancer Hospital | 2022-04-15 |
| Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea (NCT05278624) | Dermatology Consulting Services, PLLC | 2022-04-15 |
| HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy (NCT05280457) | Yonsei University | 2022-04-15 |
| Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer (NCT06706713) | BeBetter Med Inc | 2022-04-15 |
| Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors (NCT05181605) | Instituto de investigación e innovación biomédica de Cádiz | 2022-04-15 |
| Intralesional HPV Vaccine for Condylomata (NCT05087849) | University of California, San Francisco | 2022-04-15 |
| Study for the Prevention of Oral Mucositis (SPOM) (NCT05338398) | E2Bio Life Sciences, LLC | 2022-04-15 |
| Hypertension in Young Adults Trial (NCT05370599) | University of California, San Francisco | 2022-04-15 |
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) (NCT05283161) | FG Brasil LTDA | 2022-04-15 |
| Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL (NCT05322733) | The First Affiliated Hospital with Nanjing Medical University | 2022-04-15 |
| Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis (NCT05234580) | Anhui Palo Alto Pharmaceuticals, Inc. | 2022-04-15 |
| Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer (NCT05311189) | Shanghai Zhongshan Hospital | 2022-04-15 |
| HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas (NCT05180695) | Centre Leon Berard | 2022-04-15 |
| Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC (NCT05813522) | First Affiliated Hospital of Zhejiang University | 2022-04-15 |
| Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) (NCT05328102) | Xencor, Inc. | 2022-04-15 |
| The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis (NCT05406882) | West China Hospital | 2022-04-15 |
| Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation (NCT05288205) | Allist Pharmaceuticals, Inc. | 2022-04-14 |
| Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection (NCT05330455) | GlaxoSmithKline | 2022-04-14 |
| Zofin to Treat COVID-19 Long Haulers (NCT05228899) | ZEO ScientifiX, Inc. | 2022-04-14 |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases (NCT05337332) | Benha University | 2022-04-14 |
| CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma (NCT05207722) | Celularity Incorporated | 2022-04-14 |